Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapeutic Strategies for Head and Neck Cancer.
Buchwald ZS, Schmitt NC. Buchwald ZS, et al. Among authors: schmitt nc. Otolaryngol Clin North Am. 2021 Aug;54(4):729-742. doi: 10.1016/j.otc.2021.04.004. Epub 2021 Jun 9. Otolaryngol Clin North Am. 2021. PMID: 34116846 Review.
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
Ferris RL, Geiger JL, Trivedi S, Schmitt NC, Heron DE, Johnson JT, Kim S, Duvvuri U, Clump DA, Bauman JE, Ohr JP, Gooding WE, Argiris A. Ferris RL, et al. Among authors: schmitt nc. Ann Oncol. 2016 Dec;27(12):2257-2262. doi: 10.1093/annonc/mdw428. Epub 2016 Oct 11. Ann Oncol. 2016. PMID: 27733374 Free PMC article. Clinical Trial.
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.
Kansy BA, Concha-Benavente F, Srivastava RM, Jie HB, Shayan G, Lei Y, Moskovitz J, Moy J, Li J, Brandau S, Lang S, Schmitt NC, Freeman GJ, Gooding WE, Clump DA, Ferris RL. Kansy BA, et al. Among authors: schmitt nc. Cancer Res. 2017 Nov 15;77(22):6353-6364. doi: 10.1158/0008-5472.CAN-16-3167. Epub 2017 Sep 13. Cancer Res. 2017. PMID: 28904066 Free PMC article.
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Greene S, Robbins Y, Mydlarz WK, Huynh AP, Schmitt NC, Friedman J, Horn LA, Palena C, Schlom J, Maeda DY, Zebala JA, Clavijo PE, Allen C. Greene S, et al. Among authors: schmitt nc. Clin Cancer Res. 2020 Mar 15;26(6):1420-1431. doi: 10.1158/1078-0432.CCR-19-2625. Epub 2019 Dec 17. Clin Cancer Res. 2020. PMID: 31848188 Free PMC article.
Biologics in Otolaryngology: Past, Present, and Future.
Schmitt NC, Monfared A, Wise SK. Schmitt NC, et al. Otolaryngol Clin North Am. 2021 Aug;54(4):675-687. doi: 10.1016/j.otc.2021.04.001. Epub 2021 Jun 9. Otolaryngol Clin North Am. 2021. PMID: 34116845 Review.
67 results